Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.

McGough JJ, Pataki CS, Suddath R.

Expert Rev Neurother. 2005 Jul;5(4):437-41. Review.

PMID:
16026226
2.

Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder.

Kowalik S, Minami H, Silva R.

Expert Opin Pharmacother. 2006 Dec;7(18):2547-57. Review.

PMID:
17150008
3.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
4.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
6.

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L; Adult ADHD Research Group.

Biol Psychiatry. 2007 Jun 15;61(12):1380-7. Epub 2006 Nov 29.

PMID:
17137560
7.

Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

Sugrue D, Bogner R, Ehret MJ.

Am J Health Syst Pharm. 2014 Jul 15;71(14):1163-70. doi: 10.2146/ajhp130638. Review.

PMID:
24973373
8.

Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.

Tuerck D, Wang Y, Maboudian M, Wang Y, Sedek G, Pommier F, Appel-Dingemanse S.

Int J Clin Pharmacol Ther. 2007 Dec;45(12):662-8.

PMID:
18184535
9.

Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Moen MD, Keam SJ.

CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. Review.

PMID:
19958043
10.

Dexmethylphenidate for attention deficit hyperactivity disorder.

Coury D.

Expert Opin Pharmacother. 2009 Nov;10(16):2679-85. doi: 10.1517/14656560903386284.

PMID:
19874250
11.

Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.

Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R.

J Atten Disord. 2009 Mar;12(5):449-59. doi: 10.1177/1087054708320397.

PMID:
19218542
12.
13.

Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.

Silva RR, Muniz R, Pestreich L, Brams M, Mao AR, Childress A, Wang J.

J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):199-208. doi: 10.1097/chi.0b013e31815cd9a4.

PMID:
18176337
14.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
15.

Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.

May DE, Kratochvil CJ.

Drugs. 2010;70(1):15-40. doi: 10.2165/11530540-000000000-00000.

PMID:
20030423
16.

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.

Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE.

Can J Clin Pharmacol. 2006 Winter;13(1):e50-62. Epub 2006 Jan 23.

PMID:
16456216
17.

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM.

Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90.

PMID:
16389216
18.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
19.
20.

Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.

Childress AC, Spencer T, Lopez F, Gerstner O, Thulasiraman A, Muniz R, Post A.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):351-61. doi: 10.1089/cap.2009.0007.

PMID:
19702487

Supplemental Content

Support Center